Case-Based Roundtable Meetings Spotlight: December 1, 2022

December 15, 2022

After participating in a Case-Based Roundtable event led by Gavitt Woodward, MD, M. Sheila Donnelly, MD, spoke with Targeted Oncology about the patients with lung cancer she treats.

December 15, 2022

Shannon N. Westin, MD and a group of peers discussed key consideration when approaching management of a patient with ovarian cancer.

December 15, 2022

During a live event, Manish A. Shah, MD, discussed the case of a 65-year-old man presented with new onset fatigue, upper abdominal pain that worsened with eating, and unintentional weight loss.

December 14, 2022

A 54-year-old woman received a diagnosis of Revised International Staging System stage II multiple myeloma. Marc J. Braunstein, MD, PhD discussed the case with a group of peers.

December 14, 2022

Kartik Konduri, MD discussed treatment options for extensive-stage small cell lung cancer during a live virtual event.

December 14, 2022

Nizar M. Tannir, MD, discussed the case of a 59-year-old Black woman with clear cell renal cell carcinoma during a live event.

December 14, 2022

During a Targeted Oncology case-based roundtable event, Tycel Phillips, MD, discussed available therapies for a patient with relapsed/refractory diffuse large B-cell lymphoma including CAR T-cell therapy and combination systemic therapies.

December 13, 2022

During a Targeted Oncology case-based roundtable event, Susan Slovin, MD, discussed the next line of therapy for a patient with progressed metastatic castration-resistant prostate cancer with new liver metastasis.

December 12, 2022

During a Targeted Oncology case-based roundtable event, Benjamin Levy, MD, discussed the current targeted treatment options that target lung cancers that are positive for ALK rearrangements.